Complex high-risk and indicated PCI — performing revascularization in patients with severely reduced left ventricular function, multivessel disease, and high procedural risk who were historically managed medically — represents the frontier of interventional cardiology practice enabled by mechanical circulatory support, advanced imaging, and refined technique, with the Cath Lab Market reflecting the CHIP program's commercial and clinical development.

Percutaneous mechanical circulatory support using Impella devices — providing axial flow pump support augmenting forward cardiac output during high-risk PCI — enables revascularization of patients with severely depressed left ventricular function and complex multivessel disease who cannot tolerate the hemodynamic stress of conventional PCI. The PROTECT II and PROTECT III trials established outcome data for Impella-supported high-risk PCI, supporting clinical adoption at specialized cath lab centers developing CHIP programs.

Chronic total occlusion PCI — recanalization of completely occluded coronary arteries through specialized wire escalation, dissection-re-entry, and retrograde techniques — has evolved from an extraordinarily difficult procedure performed at few specialized centers toward a more broadly available technique following the development of systematic crossing approaches, dedicated CTO devices, and fellowship training programs. Success rates at experienced CTO operators exceeding ninety percent for appropriately selected lesions have enabled meaningful symptomatic and functional benefit in patients previously resigned to living with their occluded coronary territory.

Rotational atherectomy, orbital atherectomy, and intravascular lithotripsy for calcified coronary lesions inadequately dilated by conventional balloon catheters represent the lesion modification technologies enabling stent delivery and expansion in the heavily calcified coronary disease increasingly encountered in aging patient populations.

Do you think widespread MCS-supported CHIP PCI will reduce cardiac surgery referrals for complex multivessel revascularization, and what level of evidence would justify this paradigm shift?

FAQ

What is CHIP PCI? Complex High-risk and Indicated PCI refers to percutaneous coronary intervention in patients with severely depressed left ventricular function, complex multivessel disease, or high procedural risk, often using mechanical circulatory support to enable safe revascularization that conventional PCI cannot safely accomplish.

What is Impella support during PCI? Impella is a percutaneous axial flow pump inserted through the femoral artery that provides up to five liters per minute of forward cardiac output support, enabling safe performance of high-risk PCI in patients with severely reduced heart function.

#CathLab #CHIPPCI #Impella #HighRiskPCI #MechanicalSupport #CTORevascularization